GRETO, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 3.908
EU - Europa 1.733
AS - Asia 669
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 6.312
Nazione #
US - Stati Uniti d'America 3.898
PL - Polonia 540
IT - Italia 358
IE - Irlanda 353
HK - Hong Kong 254
SE - Svezia 221
CN - Cina 191
JO - Giordania 80
SG - Singapore 75
RU - Federazione Russa 72
DE - Germania 63
FI - Finlandia 35
GB - Regno Unito 28
KR - Corea 28
VN - Vietnam 17
IN - India 16
FR - Francia 15
CH - Svizzera 13
ES - Italia 13
CA - Canada 10
UA - Ucraina 9
CZ - Repubblica Ceca 5
BE - Belgio 4
TR - Turchia 4
LT - Lituania 2
UZ - Uzbekistan 2
AU - Australia 1
EU - Europa 1
GR - Grecia 1
IR - Iran 1
NL - Olanda 1
TH - Thailandia 1
Totale 6.312
Città #
Fairfield 637
Warsaw 540
Chandler 380
Ashburn 374
Dublin 351
Seattle 294
Woodbridge 277
Cambridge 271
Houston 231
Wilmington 210
Hong Kong 184
Dearborn 131
Lawrence 119
Altamura 108
Princeton 90
Beijing 87
Florence 82
Ann Arbor 75
Buffalo 61
New York 50
Medford 45
Moscow 43
Boston 42
Shanghai 42
San Diego 38
Singapore 34
Kent 31
Seoul 28
Boardman 19
Falls Church 18
West Jordan 18
Munich 14
Barcelona 13
Pune 13
Rome 13
Bern 12
Dong Ket 11
Jacksonville 10
Nanjing 9
Norwalk 9
Guangzhou 7
Hillsboro 7
Milan 7
Toronto 7
Redwood City 6
Brno 5
London 5
Phoenix 5
Prato 5
Redmond 5
Andover 4
Brussels 4
Hefei 4
Kunming 4
Paris 4
Southwark 4
Bergamo 3
Falkenstein 3
Frankfurt am Main 3
Fremont 3
Helsinki 3
Kilburn 3
Mcallen 3
Montemurlo 3
Nagold 3
Nürnberg 3
Pistoia 3
Salerno 3
Wandsworth 3
Bojano 2
Busto Arsizio 2
Calgary 2
Chicago 2
Chongqing 2
Empoli 2
Ferrara 2
Fuzhou 2
Izmir 2
Lappeenranta 2
Los Angeles 2
Nantes 2
Novate Milanese 2
Pelago 2
Romainville 2
Saint-Fons 2
San Francisco 2
San Mateo 2
Santa Clara 2
Santa Maria A Monte 2
Scarperia e San Piero 2
Somma Vesuviana 2
Tashkent 2
Vilnius 2
Washington 2
Wuhan 2
Zaozhuang 2
Zhengzhou 2
Acton 1
Aprilia 1
Berlin 1
Totale 5.195
Nome #
Hypofractionation in prostate cancer: radiobiological basis and clinical appliance. 213
Postmastectomy radiotherapy for locally advanced breast cancer receiving neoadjuvant chemotherapy. 205
Non-pegylated liposomal doxorubicin in combination with cyclophosphamide or docetaxel as first-line therapy inmetastatic breast cancer: a retrospective analysis. 180
Efficacy and tolerability of cyberknife stereotactic robotic radiotherapy for primary or secondary orbital lesions: A single-center retrospective experience 158
A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model 119
Influence of age and subtype in outcome of operable liposarcoma 117
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 116
Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO) 113
PO-0643: Scalp-sparing radiotherapy to minimize alopecia in patients with primary brain cancer 113
TomoTherapy treatments of multiple brain lesions: an in-phantom accuracy evaluation 112
Combined modality therapy for thoracic and head and neck cancers: a review of updated literature based on a consensus meeting 109
Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice 106
A PPAR-gamma agonist protects from radiation-induced intestinal toxicity 101
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study 99
Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy 98
Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial 97
Gamma Knife Radiosurgery in the management of single and multiple brain metastases 97
Radiotherapy in the age of cancer immunology: Current concepts and future developments 96
Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors? 96
Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy? 96
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 92
Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma 92
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 90
Doxorubicin and cyclophosphamideversus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvantchemotherapy in breast cancer. 88
Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility 87
Prognostic role of human epidermal growth factor receptor 2 status in premenopausal early breast cancer treated with adjuvant tamoxifen. 87
BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management 87
Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent Prostate Cancer 87
Application of helical tomotherapy for the treatment of a right atrium angiosarcoma: A case report 85
A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model 85
Stereotactic body radiotherapy with CyberKnife for cardiac malignancies 84
Complete response in metastatic renal cell carcinoma after radiotherapy and everolimus: a clinical case and review of the literature 84
Oral Lapacho-Based Medication: An Easy, Safe, and Feasible Support to Prevent and/or Reduce Oral Mucositis during Radiotherapy for Head and Neck Cancer 84
Intercomparison Study On Small Field Output Factor Measurements 83
Predictive factors for additional non-sentinel lymph node involvement in breast cancer patients with one positive sentinel node 83
Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors 83
Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review 81
Neoadjuvant oxaliplatin and 5-fluorouracil with concurrent radiotherapy in patients with locally advanced rectal cancer: a singleinstitution experience. 80
Clinical outcome of stereotactic body radiotherapy for abdominal lymph node metastases. 80
Radiomic and dosiomic profiling of paediatric medulloblastoma tumours treated with intensity modulated radiation therapy 79
Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experience 78
Re-irradiation as salvage treatment in recurrent glioblastoma: A comprehensive literature review to provide practical answers to frequently asked questions 78
A dosimetric comparison between CyberKnife and tomotherapy treatment plans for single brain metastasis 76
Soft tissue myxofibrosarcoma: A clinico-pathological analysis of a series of 75 patients with emphasis on the epithelioid variant 76
Leiomyosarcoma: Clinicopathological study and retrospective analysis of prognostic factors in a series of 100 patients 75
Stereotactic reirradiation for local failure of brain metastases following previous radiosurgery: Systematic review and meta-analysis 73
Impact of a breathing-control system on target margins and normal-tissue sparing in the treatment of lung cancer: experience at the radiotherapy unit of Florence University. 73
Impact of sentinel node tumor burden on outcome of invasive breast cancer patients. 72
Methodological approach to create an atlas using a commercial auto-contouring software 72
Management of inflammatory breast cancer: Focus on radiotherapy with an evidence-based approach. 71
PO-0873: 2D pixelated diamond detector for patient QA in advanced radiotherapy treatments 70
Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy: Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014) 68
Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO) 68
Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial 68
Outcome and prognostic factors for older patients undergoing radiosurgery for brain metastases 66
Prognostic impact of nodal relapse in definitive prostate-only irradiation 64
Neoadjuvant treatment of soft tissue sarcoma: A single center experience 63
Liposarcoma: Clinico-pathological analysis, prognostic factors and survival in a series of 307 patients treated at a single institution 63
GammaTools: A modular multifunction phantom for quality assurance in GammaKnife treatments 60
Clinical features, prognostic factors and outcome in a series of 29 extra-skeletal Ewing Sarcoma. Adequate margins and surgery-radiotherapy association improve overall survival 57
Dosimetric Predictors of Acute and Chronic Alopecia in Primary Brain Cancer Patients Treated With Volumetric Modulated Arc Therapy 57
Clinical validation of an automatic atlas-based segmentation tool for male pelvis CT images 53
Prostate cancer as a paradigm of multidisciplinary approach? highlights from the italian young radiation oncologist meeting 51
Ewing family tumors of the appendicular skeleton: a retrospective analysis of prognostic factors 45
Stereotactic Body Radiotherapy in Oligomestatic/Oligoprogressive Sarcoma: Safety and Effectiveness Beyond Intrinsic Radiosensitivity 45
Protective Effect of Leuprorelin on Radiation-induced Intestinal Toxicity 44
Impact of COVID-19 on workload burden of a complex radiotherapy facility 44
Treatment options in femoral radiation fractures following soft tissue sarcoma: Incidence, risk factors, failures and flowchart of treatment 40
Regorafenib in glioblastoma recurrence: A case report 39
Correction to: Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility (Supportive Care in Cancer, (2021), 29, 6, (2931-2937), 10.1007/s00520-020-05793-3) 39
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833) 38
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 32
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? 32
Clinical outcomes and secondary glaucoma after gamma-knife radiosurgery and Ruthenium-106 brachytherapy for uveal melanoma: a single institution experience 32
CONFORMAL RADIOTHERAPY (3DCRT) TO ATTEMPT RADICAL plus CHEMOTHERAPY +/- SURGERY IN THE TREATMENT OF EWING'S SARCOMA (EWS) BASED ON THE PELVIC AREA 32
Local treatment for relapsing glioblastoma: A decision-making tree for choosing between reirradiation and second surgery 30
Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients 26
Pleomorphic Xanthoastrocytoma: a single institution retrospective analysis and a review of the literature 24
Management of severe bio-radiation dermatitis induced by radiotherapy and cetuximab in patients with head and neck cancer: emphasizing the role of calcium alginate dressings 19
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 19
Radiomics in the setting of neoadjuvant radiotherapy: A new approach for tailored treatment 18
Brief report: pediatric high-grade gliomas treated with vinorelbine and valproic acid added to temozolomide 17
PAIDEIA: pacemaker and implanted cardioverter defibrillator management in radiation therapy—a survey by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 15
Single-fraction stereotactic body radiotherapy for oligometastatic lymph node relapse in prostate cancer 15
Robotic stereotactic radiotherapy for liver oligometastases from colorectal cancer: a single-center experience 14
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 13
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort 12
Safety and efficacy of combined radiotherapy, immunotherapy and targeted agents in elderly patients: A literature review 12
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736) 11
Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells 11
Single-fraction radiotherapy (SFRT) for bone metastases: Patient selection and perspectives 11
Radiation treatment for adult rare cancers: Oldest and newest indication 9
Evaluation of Italian radiotherapy research from 1985 to 2005: preliminary analysis 8
Radiomic- and dosiomic-based clustering development for radio-induced neurotoxicity in pediatric medulloblastoma 7
Totale 6.447
Categoria #
all - tutte 24.162
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.162


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.588 93 69 26 121 224 246 229 182 163 112 103 20
2020/2021693 69 46 28 124 30 40 46 45 74 83 61 47
2021/2022532 11 26 42 25 20 28 16 54 31 23 86 170
2022/20231.643 129 369 87 74 115 278 209 111 189 3 56 23
2023/2024862 31 63 99 33 66 131 36 229 15 54 76 29
2024/2025111 111 0 0 0 0 0 0 0 0 0 0 0
Totale 6.447